Bevacizumab and hypokalaemia 
Bevacizumab and hypokalaemia Patient Reports February 10, 2012
Bevacizumab Side Effects Report #5747665-X
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on May 08, 2008. Female patient, weighting 121.3 lb, was diagnosed with ovarian epithelial cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: blood magnesium decreased, dizziness
, fatigue, haemoglobin decreased, hypokalaemia, neuropathy peripheral, thrombocytopenia, tinnitus . Bevacizumab dosage: 412.5 MG, Q3W. During the same period patient was treated with CARBOPLATIN, PACLITAXEL. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5751407-1
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on May 14, 2008. Female patient, weighting 121.3 lb, was diagnosed with ovarian epithelial cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: blood magnesium decreased, fatigue, haemoglobin decreased, hypokalaemia, peripheral sensory neuropathy, thrombocytopenia. Bevacizumab dosage: 412.5 MG, Q3W. During the same period patient was treated with CARBOPLATIN, PACLITAXEL. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5410227-8
Bevacizumab side effect was reported by a Physician from UNITED STATES on July 31, 2007. Female patient was diagnosed with ovarian cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dehydration, hypokalaemia, hypomagnesaemia. Bevacizumab dosage: 15 MG/KG, UNK. During the same period patient was treated with CISPLATIN, TAXOL, ACETAMINOPHEN, AL HYDROXIDE, AMLODIPINE, APREPITANT, ASPIRIN, ATORVASTATIN CALCIUM. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5453904-5
Bevacizumab side effect was reported by a Physician from UNITED STATES on Sept 05, 2007. Female patient was diagnosed with ovarian cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: gastrointestinal perforation, hypokalaemia, hypomagnesaemia, hyponatraemia, septic shock. Bevacizumab dosage: 803 MG/KG, UNK. During the same period patient was treated with TAXOL, CISPLATIN, ACETAMINOPHEN, SIMETHICONE, AMBIEN, AMLODIPINE, APREPITANT. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5620647-4
Bevacizumab side effect was reported by a Physician from UNITED STATES on Feb 01, 2008. Female patient was diagnosed with ovarian cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: gastrointestinal perforation, hypokalaemia, hypomagnesaemia, hyponatraemia, septic shock. Bevacizumab dosage: 803 MG/KG, UNK. During the same period patient was treated with TAXOL, CISPLATIN, ACETAMINOPHEN, SIMETHICONE, AMBIEN, AMLODIPINE, APREPITANT. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5673697-6
Bevacizumab side effect was reported by a Physician from UNITED STATES on Mar 13, 2008. Female patient was diagnosed with ovarian cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: gastrointestinal perforation, hypokalaemia, hypomagnesaemia, hyponatraemia, septic shock. Bevacizumab dosage: 803 MG/KG, UNK. During the same period patient was treated with TAXOL, CISPLATIN, ACETAMINOPHEN, SIMETHICONE, AMBIEN, AMLODIPINE, APREPITANT. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5745905-4
Bevacizumab side effect was reported by a Pharmacist from UNITED STATES on May 13, 2008. Male patient was diagnosed with oesophageal adenocarcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: deep vein thrombosis
, dehydration, hypocalcaemia, hypokalaemia, hypomagnesaemia, neutropenia, nodule, oesophageal ulcer, oesophagitis. Bevacizumab dosage: unknown. During the same period patient was treated with CISPLATIN, IRINOTECAN. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5416836-4
Bevacizumab side effect was reported by a Physician from UNITED STATES on Aug 15, 2007. Male patient, 81 years of age, weighting 143.3 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anorexia, asthenia, dehydration, fatigue, hypernatraemia, hypokalaemia, oral intake reduced, weight decreased. Bevacizumab dosage: 1050 MG Q21 DAYS IV. During the same period patient was treated with PEMETREXED, ERLOTINIB, PROSCAR, INDAPAMIDE, LISINOPRIL, TERAZOSIN, LIPITOR, POTASSIUM CHLORIDE. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5147188-5
Bevacizumab side effect was reported by a Health Professional from CANADA on Oct 18, 2006. Male patient, 65 years of age, weighting 163.1 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: asthenia, colitis, cough, hypokalaemia, ileus, leukocytosis, nausea
, pneumothorax, sputum discoloured. Bevacizumab dosage: 15 MG/KG, Q3W, INTRAVENOUS. During the same period patient was treated with CISPLATIN, GEMCITABINE, DOCUSATE, PROCHLORPERAZINE, SENOKOT, ZANTAC, POTASSIUM CHLORIDE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #4967125-3
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 17, 2006. Female patient, 64 years of age, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, arteriosclerosis, blood pressure increased, confusional state, convulsion, hypertension, hypertensive encephalopathy, hypokalaemia, malignant neoplasm progression. Bevacizumab dosage: unknown. During the same period patient was treated with PACILTAXEL, ACETAMINOPHEN, LABETALOL, ROCEPHIN, TOPROL, LISINOPRIL, AMPICILLIN. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5326628-2
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on May 01, 2007. Female patient was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain
, fatigue, hypokalaemia. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with TAXOL, CARBOPLATIN. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5369841-0
Bevacizumab side effect was reported by a Physician from UNITED STATES on June 18, 2007. Male patient, weighting 197.0 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: hypokalaemia. Bevacizumab dosage: 1340 MG, Q3W. During the same period patient was treated with TAXOL, CARBOPLATIN. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5382028-0
Bevacizumab side effect was reported by a Physician from UNITED STATES on June 27, 2007. Male patient, weighting 197.0 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: hypokalaemia. Bevacizumab dosage: 1340 MG, Q3W. During the same period patient was treated with TAXOL, CARBOPLATIN, XANAX, PRAVACHOL, ALTACE, SINGULAIR, NEXIUM, AMBIEN. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5387633-3
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on July 06, 2007. Female patient, weighting 150.0 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, asthenia, dehydration, dizziness
, hypokalaemia. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with ALIMTA, CARBOPLATIN, RADIATION. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5395518-1
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on July 19, 2007. Female patient, weighting 150.0 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, asthenia, dehydration, dizziness
, hypokalaemia. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with ALIMTA, CARBOPLATIN, RADIATION, FOLIC ACID. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5419471-7
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Aug 14, 2007. Male patient, weighting 142.2 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anorexia, dehydration, fatigue, hypernatraemia, hypokalaemia, weight decreased. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with ERLOTINIB, PEMETREXED, PROSCAR, INDAPAMIDE, LISINOPRIL, TERAZOSIN, LIPITOR, POTASSIUM CHLORIDE. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5444002-5
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Aug 29, 2007. Male patient, weighting 142.2 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anorexia, dehydration, fatigue, hypernatraemia, hypokalaemia, weight decreased. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with ERLOTINIB, PEMETREXED, PROSCAR, INDAPAMIDE, LISINOPRIL, TERAZOSIN, LIPITOR, POTASSIUM CHLORIDE. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5531794-X
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Nov 27, 2007. Male patient, weighting 166.4 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dyspnoea exertional, hypokalaemia, hyponatraemia, neutropenia. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with CARBOPLATIN, GEMCITABINE, NEURONTIN, PRILOSEC, IRON SUPPLEMENT, DECADRON. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5546437-9
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Dec 04, 2007. Male patient, weighting 166.4 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dyspnoea exertional, hypokalaemia, hyponatraemia, hypoxia, neutropenia. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with CARBOPLATIN, GEMCITABINE, NEURONTIN, PRILOSEC, IRON SUPPLEMENT, DECADRON. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5607778-X
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Jan 24, 2008. Male patient, weighting 166.4 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dyspnoea exertional, hypokalaemia, hyponatraemia, hypoxia, neutropenia. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with CARBOPLATIN, GEMCITABINE, NEURONTIN, PRILOSEC, IRON SUPPLEMENT, DECADRON. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5618351-1
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Jan 24, 2008. Female patient, weighting 110.2 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: hypokalaemia. Bevacizumab dosage: 420 MG, Q3W. During the same period patient was treated with CISPLATIN, VINORELBINE, BISOPROLOL FUMARATE, ACARD, METOCLOPRAMIDE. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5717778-7
Bevacizumab side effect was reported by a Physician from UNITED STATES on Apr 17, 2008. Male patient was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: blepharitis, blood albumin decreased, confusional state, haemoglobin decreased, hypocalcaemia, hypokalaemia, platelet count decreased. Bevacizumab dosage: 960 MG, Q3W. During the same period patient was treated with CARBOPLATIN, GEMZAR. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #6014937-3
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Dec 12, 2008. Male patient, weighting 147.7 lb, was diagnosed with neuroendocrine carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dehydration, hypokalaemia, orthostatic hypotension. Bevacizumab dosage: 7.5 MG/KG, UNK. During the same period patient was treated with XELODA, HYTRIN, AVODART, PRILOSEC, MARINOL, CELEXA. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #6127181-6
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Mar 12, 2009. Male patient, weighting 147.7 lb, was diagnosed with neuroendocrine carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dehydration, hypokalaemia, orthostatic hypotension. Bevacizumab dosage: 7.5 MG/KG, UNK. During the same period patient was treated with XELODA, HYTRIN, AVODART, PRILOSEC, MARINOL, CELEXA. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5384847-3
Bevacizumab side effect was reported by a Physician from UNITED STATES on July 03, 2007. Male patient, 72 years of age, was diagnosed with metastatic gastric cancer, insomnia and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dehydration, hypokalaemia, wound infection. Bevacizumab dosage: 10 MG/KG, UNK. During the same period patient was treated with DOCETAXEL, CISPLATIN, IRINOTECAN, NEXIUM, NORVASC, ATIVAN, DECADRON, ZOFRAN. Patient recovered.
Bevacizumab Side Effects Report #5324283-9
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on May 04, 2007. Male patient, weighting 161.0 lb, was diagnosed with metastatic gastric cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain
, diarrhoea, hypokalaemia, mucosal inflammation, nausea . Bevacizumab dosage: 10 MG/KG, UNK. During the same period patient was treated with DOCETAXEL, CISPLATIN, IRINOTECAN, ATIVAN, COMPAZINE, DECADRON, FENTANYL, MIRALAX. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5328627-3
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on May 14, 2007. Male patient, weighting 161.0 lb, was diagnosed with metastatic gastric cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain
, diarrhoea, hypokalaemia, mucosal inflammation, nausea . Bevacizumab dosage: 10 MG/KG, UNK. During the same period patient was treated with DOCETAXEL, CISPLATIN, IRINOTECAN, ATIVAN, COMPAZINE, DECADRON, FENTANYL, MIRALAX. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5688889-X
Bevacizumab side effect was reported by a Physician from UNITED STATES on Mar 24, 2008. Male patient, 69 years of age, weighting 146.4 lb, was diagnosed with colorectal cancer metastatic, hypertension and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: hypokalaemia. Bevacizumab dosage: 5 MG/KG, DAYS 1+15. During the same period patient was treated with OXALIPLATIN, IRINOTECAN, NORVASC. Patient recovered.
Bevacizumab Side Effects Report #5601703-3
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Jan 09, 2008. Male patient, weighting 178.6 lb, was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: hypokalaemia, proteinuria. Bevacizumab dosage: 610 MG, Q2W. During the same period patient was treated with CAPECITABINE, CAMPTO, TRIFLUCAN, ZOMETA, ALLOPURINOL, AMLOR, BISOPROLOL FUMARATE. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5616166-1
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Jan 25, 2008. Male patient, weighting 169.8 lb, was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: diarrhoea, hypokalaemia, pyrexia. Bevacizumab dosage: unknown. During the same period patient was treated with CAPECITABINE, OXALIPLATIN, TEBETANE COMPUESTO, OMEPRAZOLE. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5626053-0
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Feb 04, 2008. Male patient, weighting 178.6 lb, was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: hypokalaemia, proteinuria. Bevacizumab dosage: 610 MG, Q2W. During the same period patient was treated with CAPECITABINE, CAMPTO, TRIFLUCAN, ZOMETA, ZYLORIC, AMLOR, BISOPROLOL FUMARATE. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5174214-X
Bevacizumab side effect was reported by a Physician from UNITED STATES on Nov 22, 2006. Male patient, 61 years of age, weighting 177.3 lb, was diagnosed with colorectal cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, diarrhoea, hypokalaemia, hypomagnesaemia, hyponatraemia, hypophosphataemia, intestinal obstruction, nausea . Bevacizumab dosage: 5 MG/KG, Q2W, INTRAVENOUS. During the same period patient was treated with OXALIPLATIN, ATENOLOL, PLAVIX, DIOVAN, COMPAZINE, IMODIUM, VITAMIN B, FOLIC ACID. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5187716-7
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Dec 05, 2006. Male patient, 61 years of age, weighting 177.3 lb, was diagnosed with colorectal cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: blood sodium decreased, hypokalaemia, intestinal obstruction. Bevacizumab dosage: 5 MG/KG Q2W INTRAVENOUS. During the same period patient was treated with OXALIPLATIN, ATENOLOL, PLAVIX, DIOVAN, COMPAZINE, IMODIUM, VITMAIN B, FOLIC ACID. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5198024-2
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Dec 19, 2006. Male patient, 61 years of age, weighting 177.3 lb, was diagnosed with colorectal cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: adhesion , diarrhoea, hypokalaemia, hypomagnesaemia, hyponatraemia, hypophosphataemia, intestinal obstruction, metastases to peritoneum, nausea . Bevacizumab dosage: 5 MG/KG, Q2W, INTRAVENOUS. During the same period patient was treated with OXALIPLATIN, CAPECITABINE, ATENOLOL, PLAVIX, DIOVAN, COMPAZINE, IMODIUM, VITAMIN B. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5306023-2
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Apr 24, 2007. Male patient, weighting 177.3 lb, was diagnosed with colorectal cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: hypokalaemia, hypomagnesaemia, hyponatraemia, hypophosphataemia, intestinal obstruction, metastases to peritoneum. Bevacizumab dosage: 5 MG/KG, Q2W. During the same period patient was treated with OXALIPLATIN, CAPECITABINE, ATENOLOL, PLAVIX, DIOVAN, COMPAZINE, IMODIUM, VITAMIN B. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5322518-X
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Apr 26, 2007. Male patient was diagnosed with colorectal cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dehydration, diarrhoea, fistula , hypokalaemia. Bevacizumab dosage: 525 MG, Q3W. During the same period patient was treated with CAPECITABINE, OXALIPLATIN, LOPERAMIDE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5734164-4
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Mar 31, 2008. Male patient was diagnosed with colorectal cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: hypokalaemia, hyponatraemia. Bevacizumab dosage: 5 MG/KG, Q2W. During the same period patient was treated with OXALIPLATIN, LEUCOVORIN CALCIUM, FLUOROURACIL. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5966855-4
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Nov 12, 2008. Male patient was diagnosed with colorectal cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: blood creatinine increased, dehydration, diarrhoea, hypokalaemia, renal failure. Bevacizumab dosage: 7.5 MG/KG, UNK. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL, LEUCOVORIN CALCIUM, CETUXIMAB, IRINOTECAN HYDROCHLORIDE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5700848-7
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Mar 27, 2008. Male patient was diagnosed with colon cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: hypokalaemia. Bevacizumab dosage: 5 MG/KG, UNK. During the same period patient was treated with FLUOROURACIL, ISOVORIN, VITAMEDIN, VITAMIN A. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5869317-8
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Aug 20, 2008. Male patient, weighting 119.0 lb, was diagnosed with colon cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: hypokalaemia. Bevacizumab dosage: 5 MG/KG, QD. During the same period patient was treated with FLUOROURACIL, ISOVORIN, VITAMEDIN, VITAMIN A. Patient recovered.
Bevacizumab Side Effects Report #4934938-3
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Mar 03, 2006. Male patient, 73 years of age, weighting 141.0 lb, was diagnosed with colon cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: asthenia, bacteraemia, dehydration, dyspnoea, hypokalaemia, international normalised ratio increased, pulmonary embolism
, renal failure acute, staphylococcal infection . Bevacizumab dosage: 5 MG/KG DAY 1 IV. During the same period patient was treated with OXALIPLATIN, LEUCOVORIN CALCIUM, FLUOROURACIL, ERLOTINIB, ACTOS, COMPAZINE, GLIPIZIDE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5503210-5
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Oct 16, 2007. Female patient, weighting 135.6 lb, was diagnosed with colon cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: diarrhoea, hypokalaemia, vomiting. Bevacizumab dosage: 326 MG, Q2W. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL, LEUCOVORIN, RABEPRAZOLE, ZOFRAN, PROCHLORPERAZINE, ALUMINUM HYDROXIDE GEL, NORVASC. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5720506-2
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Apr 10, 2008. Male patient was diagnosed with colon cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dehydration, diarrhoea, gastrointestinal obstruction, hypokalaemia, hyponatraemia, hypophosphataemia, infection
, nausea , neutrophil count decreased. Bevacizumab dosage: 5 MG/KG, Q2W. During the same period patient was treated with CAPECITABINE, ELOXATIN, LEUCOVORIN CALCIUM, FLUOROURACIL. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5739576-0
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on May 02, 2008. Male patient was diagnosed with colon cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: diarrhoea, gastrointestinal obstruction, hypokalaemia, hypophosphataemia, infection
, nausea . Bevacizumab dosage: 5 MG/KG, Q2W. During the same period patient was treated with XELODA, ELOXATIN, LEUCOVORIN CALCIUM, FLUOROURACIL. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5886570-5
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Sept 02, 2008. Male patient was diagnosed with colon cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: diarrhoea, embolism, hypokalaemia. Bevacizumab dosage: 5 MG/KG, Q2W. During the same period patient was treated with OXALIPLATIN, LEUCOVORIN CALCIUM, FLUOROURACIL. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5847145-7
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Aug 01, 2008. Female patient was diagnosed with breast cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anorexia, dehydration, diarrhoea, dizziness , dyspnoea, fatigue, headache , hypokalaemia, lethargy. Bevacizumab dosage: 10 MG/KG, DAYS 2+16. During the same period patient was treated with TAXOL. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5866121-1
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Aug 14, 2008. Female patient was diagnosed with breast cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: hypokalaemia, neutropenia, oesophageal candidiasis, pneumonitis. Bevacizumab dosage: 945 MG/KG, Q2W. During the same period patient was treated with ADRIAMYCIN PFS, CYTOXAN, ATIVAN, ZOFRAN, MOTRIN. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5872557-5
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Aug 21, 2008. Female patient was diagnosed with breast cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: hypokalaemia, neutropenia, oesophageal candidiasis, pneumonitis. Bevacizumab dosage: 945 MG/KG, Q2W. During the same period patient was treated with ADRIAMYCIN PFS, CYTOXAN, ATIVAN, ZOFRAN, MOTRIN. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #6054349-X
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Jan 12, 2009. Female patient was diagnosed with breast cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: cough, hypokalaemia, neutropenia, oesophageal candidiasis, pneumonitis. Bevacizumab dosage: 945 MG/KG, Q2W. During the same period patient was treated with ADRIAMYCIN PFS, ADRIAMYCIN PFS, CYTOXAN, ATIVAN, ZOFRAN, MOTRIN, TYLENOL. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #6056961-0
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Jan 14, 2009. Female patient was diagnosed with breast cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: hypokalaemia, nausea . Bevacizumab dosage: 1710 MG, Q3W. During the same period patient was treated with FLUOROURACIL, EPIRUBICIN, CYCLOPHOSPHAMIDE, LIPITOR, OMEPRAZOLE, NEXIUM, FUROSEMIDE, NULYTELY. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #6082637-X
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Feb 03, 2009. Female patient was diagnosed with breast cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: hypokalaemia, nausea . Bevacizumab dosage: 1710 MG, Q3W. During the same period patient was treated with FLUOROURACIL, EPIRUBICIN, CYCLOPHOSPHAMIDE, LIPITOR, OMEPRAZOLE, NEXIUM, FUROSEMIDE, NULYTELY. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #6084077-6
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Feb 04, 2009. Female patient was diagnosed with breast cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: asthma , hypokalaemia, neutropenia, oesophageal candidiasis, pneumonitis. Bevacizumab dosage: 945 MG/KG, Q2W. During the same period patient was treated with ADRIAMYCIN PFS, ADRIAMYCIN PFS, CYTOXAN, ATIVAN, ZOFRAN, MOTRIN, TYLENOL. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #6094648-9
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Feb 11, 2009. Female patient was diagnosed with breast cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: asthma , hypokalaemia, neutropenia, oesophageal candidiasis, pneumonitis. Bevacizumab dosage: 945 MG/KG, Q2W. During the same period patient was treated with ADRIAMYCIN PFS, ADRIAMYCIN PFS, CYTOXAN, ATIVAN, ZOFRAN, MOTRIN, TYLENOL. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #6098280-2
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Aug 14, 2008. Female patient was diagnosed with breast cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: hypokalaemia. Bevacizumab dosage: 945 MG/KG, Q2W. During the same period patient was treated with DOXORUBICIN, CYTOXAN, LORAZEPAM, ZOFRAN, MOTRIN, TYLENOL, EMEND, CLOXACILINA. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5931852-1
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Oct 13, 2008. Female patient was diagnosed with adenocarcinoma pancreas and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: hypokalaemia. Bevacizumab dosage: 10 MG/KG, DAYS 1+15. During the same period patient was treated with GEMCITABINE, CISPLATIN. Patient recovered.
Bevacizumab Side Effects Report #6018658-2
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Dec 10, 2008. Female patient was diagnosed with adenocarcinoma pancreas and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: hypokalaemia. Bevacizumab dosage: 10 MG/KG, DAYS 1+15. During the same period patient was treated with GEMCITABINE, CISPLATIN. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #6048754-5
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Jan 09, 2009. Female patient was diagnosed with adenocarcinoma pancreas and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: hypokalaemia. Bevacizumab dosage: 10 MG/KG, DAYS 1+15. During the same period patient was treated with GEMCITABINE, CISPLATIN. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5304981-3
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 17, 2007. Female patient, 53 years of age, was diagnosed with mucosal inflammation, cough, urinary tract infection
, hyperuricaemia, pain , gastrointestinal disorder and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, hypokalaemia, nerve root compression. Bevacizumab dosage: 569 MG, Q2W. During the same period patient was treated with INTERLEUKIN, DEMEROL, NYSTATIN, HYCODAN, LEVAQUIN, ALLOPURINOL, DURAGESIC, CARAFATE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5015282-5
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on May 30, 2006. Female patient, 51 years of age, weighting 144.0 lb, was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, hypokalaemia, hypotension, immunosuppression, inadequate diet, odynophagia, oral intake reduced, pneumonia aspiration. Bevacizumab dosage: BEVACIZUMAB 10MG/KG. During the same period patient was treated with TARCEVA. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5015297-7
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on May 30, 2006. Female patient, 51 years of age, weighting 144.0 lb, was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, hypokalaemia, hypotension, immunosuppression, inadequate diet, odynophagia, oral intake reduced, pneumonia aspiration. Bevacizumab dosage: BEVACIZUMAB 10MG/KG. During the same period patient was treated with TARCEVA. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5381247-7
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on June 26, 2007. Female patient, weighting 150.0 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, dehydration, hypokalaemia. Bevacizumab dosage: 15 MG/KG, UNK. During the same period patient was treated with ALIMTA, CARBOPLATIN, RADIATION. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5657331-7
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 07, 2008. Male patient, weighting 146.4 lb, was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: hypokalaemia. Bevacizumab dosage: 674 MG. During the same period patient was treated with ELOXATIN, CAMPTOSAR, NORVASC. Patient recovered.